91 related articles for article (PubMed ID: 24598661)
1. [Clinical significance of serum vascular endothelial growth factor in patients with multiple myeloma].
Li X; Wei XZ; Liu JW; Geng CY; Chen WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):108-11. PubMed ID: 24598661
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Shen JK; Dong LH; Qi H; Zhang GS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of vascular endothelial growth factor and cyclooxygenase-2 in patients with multiple myeloma and its significance].
Bao HY; Zhu MQ; Jiang M; Dong NZ; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):99-101. PubMed ID: 19236756
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum vascular endothelial growth factor and interleukin-17 in patients with multiple myeloma].
Dong SS; Li GL; Yang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):344-7. PubMed ID: 22541095
[TBL] [Abstract][Full Text] [Related]
5. [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma].
Usnarska-Zubkiewicz L; Mazur G; Wróbel T; Poreba M; Kuliczkowski K
Pol Arch Med Wewn; 2003 Jul; 110(1):719-24. PubMed ID: 14682206
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Value of Serum Fructosamine Measurement in IgA Type Multiple Myeloma].
Zhang JY; Fan H; Chen LX; Wang LF; Wang HF; Shi HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):494-497. PubMed ID: 28446300
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
8. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
9. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
10. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
11. [Significance of the ratio of plasma vascular endothelial growth factor level to platelet count in the prognosis of patients with sepsis].
Jiang W; Ouyang W; Chen C; Zhu G; Huang L; Zeng H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):484-8. PubMed ID: 25027426
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
13. [Study on the high expression of brain-derived neurotrophic factor in multiple myeloma patients and its possible mechanism].
Hu Y; Sun CY; Wang YD; Wei WN; Wu T; He WJ; Zhao S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):104-9. PubMed ID: 15748446
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study of the serum vascular endothelial growth factor in patients with severe sepsis].
Liu Y; Song SD; Wang HX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):172-4. PubMed ID: 19278589
[TBL] [Abstract][Full Text] [Related]
15. [Expression of midkine and vascular endothelial growth factor in bone marrow of patients with multiple myeloma and its significance].
Gao SJ; Li GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1464-7. PubMed ID: 20030927
[TBL] [Abstract][Full Text] [Related]
16. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
Urbańska-Ryś H; Robak T
Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
18. [Serum level of IL-17 in patients with multiple myeloma and its clinical significance].
Zhang XL; Zhang WH; Fan XH; Wei F; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):930-2. PubMed ID: 22931657
[TBL] [Abstract][Full Text] [Related]
19. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
